Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 1
1989 5
1990 2
1991 7
1992 10
1993 16
1994 27
1995 32
1996 40
1997 33
1998 30
1999 30
2000 28
2001 21
2002 26
2003 22
2004 25
2005 25
2006 22
2007 14
2008 17
2009 21
2010 20
2011 19
2012 17
2013 18
2014 18
2015 23
2016 19
2017 11
2018 18
2019 21
2020 18
2021 24
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

647 results
Results by year
Filters applied: . Clear all
Page 1
BHRF1, a BCL2 viral homolog, disturbs mitochondrial dynamics and stimulates mitophagy to dampen type I IFN induction.
Vilmen G, Glon D, Siracusano G, Lussignol M, Shao Z, Hernandez E, Perdiz D, Quignon F, Mouna L, Poüs C, Gruffat H, Maréchal V, Esclatine A. Vilmen G, et al. Autophagy. 2021 Jun;17(6):1296-1315. doi: 10.1080/15548627.2020.1758416. Epub 2020 May 13. Autophagy. 2021. PMID: 32401605 Free PMC article.
This response is notably due to their role in the activation of interferon (IFN) signaling pathways through the activity of MAVS (mitochondrial antiviral signaling protein) present at the mitochondrial surface. Here, we report that the BHRF1 protein, a BCL2 homolog encoded …
This response is notably due to their role in the activation of interferon (IFN) signaling pathways through the activity of MAVS (mitochondr …
New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA, Brown LE, Prakash S, Bhargava P. Ganapathi KA, et al. Pathology. 2021 Apr;53(3):349-366. doi: 10.1016/j.pathol.2021.01.002. Epub 2021 Mar 5. Pathology. 2021. PMID: 33685720 Review.
Recommendations in the immunohistochemical evaluation of diffuse large B-cell lymphoma include determining cell of origin and expression of MYC and BCL2, so called 'double-expressor' phenotype. EBV-positive large B-cell lymphoma of the elderly has been renamed to re …
Recommendations in the immunohistochemical evaluation of diffuse large B-cell lymphoma include determining cell of origin and expression of …
EBV+ high-grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a multi-institutional study.
Liu H, Xu-Monette ZY, Tang G, Wang W, Kim Y, Yuan J, Li Y, Chen W, Li Y, Fedoriw GY, Zhu F, Fang X, Luedke C, Medeiros LJ, Young KH, Hu S. Liu H, et al. Histopathology. 2022 Feb;80(3):575-588. doi: 10.1111/his.14585. Epub 2021 Dec 16. Histopathology. 2022. PMID: 34637146
After a median follow-up of 36.3 months (range = 2.0-41.6), seven patients died, with a median survival of 15.4 months (range = 3.4-47.3) after diagnosis of EBV(+) DHL/THL. ...Our findings expand the spectrum of EBV(+) B cell lymphomas currently recogn …
After a median follow-up of 36.3 months (range = 2.0-41.6), seven patients died, with a median survival of 15.4 months (range = 3. …
Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer.
Nahand JS, Khanaliha K, Mirzaei H, Moghoofei M, Baghi HB, Esghaei M, Khatami AR, Fatemipour M, Bokharaei-Salim F. Nahand JS, et al. BMC Cancer. 2021 Aug 17;21(1):926. doi: 10.1186/s12885-021-08658-y. BMC Cancer. 2021. PMID: 34399719 Free PMC article.
BACKGROUND: This study aimed to evaluate the possible role of human papillomavirus (HPV) and Epstein-Barr virus (EBV) coinfection as an etiological factor for prostate cancer (PCa) development. ...The high-risk types of HPV, that is, HPV 16 and HPV 18, were responsi …
BACKGROUND: This study aimed to evaluate the possible role of human papillomavirus (HPV) and Epstein-Barr virus (EBV) coinfect …
EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management.
Ok CY, Li L, Young KH. Ok CY, et al. Exp Mol Med. 2015 Jan 23;47(1):e132. doi: 10.1038/emm.2014.82. Exp Mol Med. 2015. PMID: 25613729 Free PMC article. Review.
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, affecting >90% of the adult population. EBV targets B-lymphocytes and achieves latent infection in a circular episomal form. ...
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, affecting >90% of the adult population. EBV targets B-lymphocy …
EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features.
Chapman JR, Bouska AC, Zhang W, Alderuccio JP, Lossos IS, Rimsza LM, Maguire A, Yi S, Chan WC, Vega F, Song JY. Chapman JR, et al. Br J Haematol. 2021 Sep;194(5):870-878. doi: 10.1111/bjh.17708. Epub 2021 Jul 17. Br J Haematol. 2021. PMID: 34272731
Thirty HIV-DLBCL were identified, with a median patient age of 46 years and male predominance (5:1). Thirteen cases (48%) were EBV-positive and 14 (52%) EBV-negative. Nine of the 16 tested cases (56%) had MYC rearrangement, three (19%) had BCL6 (two of which were do …
Thirty HIV-DLBCL were identified, with a median patient age of 46 years and male predominance (5:1). Thirteen cases (48%) were EBV-po …
Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes.
Zhou Y, Xu Z, Lin W, Duan Y, Lu C, Liu W, Su W, Yan Y, Liu H, Liu L, Zhong M, Zhou J, Zhu H. Zhou Y, et al. Front Oncol. 2019 Jul 25;9:683. doi: 10.3389/fonc.2019.00683. eCollection 2019. Front Oncol. 2019. PMID: 31403034 Free PMC article.
Despite advances in genomic profiling and precision medicine in DLBCL, EBV+ DLBCL remain poorly characterized and understood. We include 236 DLBCL patients for EBV-encoded mRNA (EBER) in situ hybridization detection and analyzed 9 EBV+ and 6 EBV negati …
Despite advances in genomic profiling and precision medicine in DLBCL, EBV+ DLBCL remain poorly characterized and understood. We incl …
Mechanism of action of EBV, Bcl-2, p53, c-Myc and Rb in non-Hodgkin's lymphoma.
Song W, Liu MG, Zhang JB, Zhang JJ, Sun MM, Yu QK. Song W, et al. Eur Rev Med Pharmacol Sci. 2016;20(6):1093-7. Eur Rev Med Pharmacol Sci. 2016. PMID: 27049262 Free article.
Besides, the correlation of EBV with p53, Bcl-2, Rb and c-Myc were investigated in NHLs of observation group. ...CONCLUSIONS: The expressions of EBV(+), p53(+), Bcl-2(+), Rb(-), and c-Myc(+) are closely associated with NHL pathogenesis. ...
Besides, the correlation of EBV with p53, Bcl-2, Rb and c-Myc were investigated in NHLs of observation group. ...CONCLUSIONS: The exp …
EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins.
Fitzsimmons L, Cartlidge R, Chang C, Sejic N, Galbraith LCA, Suraweera CD, Croom-Carter D, Dewson G, Tierney RJ, Bell AI, Shannon-Lowe C, Herold MJ, Rickinson AB, Colman PM, Huang DCS, Strasser A, Kvansakul M, Rowe M, Kelly GL. Fitzsimmons L, et al. Cell Death Differ. 2020 May;27(5):1554-1568. doi: 10.1038/s41418-019-0435-1. Epub 2019 Oct 23. Cell Death Differ. 2020. PMID: 31645677 Free PMC article.
Epstein-Barr virus (EBV), which is ubiquitous in the adult population, is causally associated with human malignancies. Like many infectious agents, EBV has evolved strategies to block host cell death, including through expression of viral homologues of cellul …
Epstein-Barr virus (EBV), which is ubiquitous in the adult population, is causally associated with human malignancies. Like ma …
647 results